6. Contrast media I: general imaging and CT Flashcards
what does the contrast media do
changes density of structures in the body and improves visualisation
what will an ideal contrast agent do
provide opacification without altering physiology
what is the atomic number level of positive contrast media
high atomic number
what is the atomic number level of negative contrast media
low atomic number
what does positive contrast media do to the opacity
increases opacity
what does negative contrast media do to the opacity
decreases opacity
what are 2 examples of positive contrast media
iodine and barium
what are 2 examples of negative contrast media
air or CO2
what are the soluble and insoluble positive contrast media
iodinated CM = soluble
barium sulphate = insoluble
what is the functional group of all iodinated contrast media - ie what are they all derived from
derived from tri-iodinated benzene rings
what are 3 reasons that iodine is used
high atomic number for radiopacity
can form soluble compound with low toxicity
suitable for injection into human body
what are the 5 key properties of iodinated CM
iodine conc osmolality ionicity chemical structure viscosity
what does iodine concentration affect for iodinated CM
affects the degree of contrast
the higher the conc of iodine what effect does this have for iodinated CM
what is the pro and con
pro = better opacification con = higher risk of adverse reactions
higher conc of iodine means what for the osmolality and viscosity
higher for both
what does the choice of iodine conc depend on - 2 things
patient and type of exam
can ionic agents contain different ratio of iodinated compounds
yes
what is osmolality
measure of solute particles
what is osmolality expressed as
milliosmoles per Kg of water
osm/kg or mOsm/kg
in normal water how does water diffuse
in both directions so 0 net movement and volume remains constant
what will a CM administration to water do
create a conc difference
what is responsible for the flow of fluids to maintain balance
osmotic pressure
what are osmolality and osmolarity measures of
solute particles
what is the osmolarity
osmalal conc expressed as milliosmoles per L of soln
Osm/L or mOsm/L
what is osmolality based on
number of solutes based on weight
what is osmolarity based on
number of solutes based on volume
osmolarity is dependent on what
why
temperature as body volume is dependent temp
is osmolality dependent on temperature
why
no as it is based on mass
what is a osmole
one osmole is one gram of molecular weight of osmotically active solute
what is the tonicity related to
the impact of the osmolality of a soln on the surrounding cells
what is the osmolality of a isotonic soln relative to blood
what impact does this have on surrounding cells
similar
no impact on surrounding cells
what is the osmolality of a hypertonic soln relative to blood
what impact does this have on surrounding cells
higher than blood
water is drawn out of the cells
what is the osmolality of a hypotonic soln relative to blood
what impact does this have on surrounding cells
lower than blood
water is taken into cells
what are the 3 groups of osmolality CM can be classified into
high, low and iso-osmolar
what is the mOsm/kg of high osmolar CM
> 1400mOsm/kg
what is the mOsm/kg of low osmolar CM
780-800mOsm/kg
what is the mOsm/kg of iso-osmolar CM
290mOsm/kg
similar to plasma
most ICM are what osmolar
hyperosmolar
high osmolality have what effects on reactions
high reactions
what kind of osmolality of CM has better tolerance
closer the osmolality of CM to body fluid
tolerability and safety improves with ___/___-osmolar agents
low/iso-osmolar
what will hyperosmolar iodinated CM do to the water movement in the body
Iodinated CM are hyperosmolar in relation to blood so administration will cause movement of water into vascular compartment so water is pulled from tissues into vasculature leading to expansion of blood volume
what are the vascular effects of injection of hyperosmolar ICM in terms of plasma osmolality and water movement
increases plasma osmolality and water moves out from cells and extracellular spaces
fluid from cells in interstitial space to move into vascular lumen and dilutes the osmotically active particles
what are the vascular effects of injection of hyperosmolar ICM in terms of haematocrit and plasma volume
decrease in both
why does the plasma volume decrease after injection of hyperosmolar ICM
due to rapid clearance of ICM and diuretic effect of hyperosmolality on the kidney
Urine becomes hyperosmolar when CM is excreted into it so Promote production of urine = diuretic effect
what does hemodilution do to blood electrolytes
transient decrease in blood electrolytes
what are the 4 vascular effects of ICM
haemodilution
increase in blood viscosity
peripheral arterial vasodilation
vasodilation
what does peripheral arterial vasodilation from ICM lead to
transient hypotension
what does vasodilation from ICM lead to in terms of intravascular volume and CO
increase in both
how can IV injection of hyperosmolar fluids temp disrupt the BBB
impair the BBB impermeability
transient reversible opening of intracellular junctions
how much damage to the endothelial cells does low osmolality CM cause compared to HOCM
less damage
how does HOCM damage endothelial cells
water loss = shrinkage and damage
what aspect of ICM interaction with BBB can explain some adverse clinical symptoms
direct contact with CM and areas that lack BBB
what are 6 effects of hyperosmolality
sensation of heat/discomfort endothelium damage BBB damage renal damage thrombosis and thrombophlebitis disturbance of electrolyte balance in small children
how does hypo osmolality lead to thrombosis and thrombophlebitis
Hypoosmolality CM can lead to hypo tension and hyper viscosity of blood which can predispose patients to thrombosis and thrombophlebitis
how does hypo osmolality lead to renal damage
Osmotic shift between intra and extravascular compartments can lead to renal damage
how does hypo osmolality lead to vasovagal reaction
If the hypo osmolar CM is injected into carotid arteries can result in intra arterial osmotic pressure changes that can stimulate receptors involved in vascular homeostasis such as baroreceptors and chemoreceptors and these can lead to a vasovagal reaction resulting in hypotension and bradycardia
what is ionicity about
molecules break up or dissociate into positive cations and negative anions (charged)
what osmolality are ionic CM
higher osmolality
what osmolality are non ionic CM
lower osmolality
do ionic or non ionic CM dissociate
ionic = yes dissociate in soln
non ionic = no its soluble but remain as one particle in soln
what is the pro and con of meglumine salts compared to sodium salts
meglumine has better solubility but has higher viscosity
what is the difference between a monomer and a dimer
monomer is one benzene ring
dimer is 2 benzene rings
what is the ratio equation for iodinated CM
ratio = number of iodine atoms/number of particles
what is ratio 1.5 media like in terms of structure and dissociation
ionic monomer dissociates to form cation and anion
what is ratio 3 media like in terms of structure and dissociation
2 options
ionic dimer dissociates to form cation and anion
non ionic monomer
what is ratio 6 media like in terms of structure and dissociation
non ionic dimer
what is viscosity
measure of fluidity of a soln
what is the unit for viscosity
milipascal second (mPa.s)
what does high viscosity mean in terms of contrast
thicker contrast
what can thicker high viscosity contrast do to the body and what does it mean for the delivery of the CM (3 things)
cause friction and resistance when it travels through the body
more pressure needed to deliver CM
injection can cause discomfort
lower rate of flow so needs longer infusion times
what viscosity allows the use of rapid bolus
low viscosity
how does increasing iodine conc influence the viscosity
increases viscosity
how does the size of the molecule influence the viscosity
larger molecules have higher viscosity
how does the temperature influence the viscosity
increase temp means lower viscosity
what are 2 advantages of using intra arterial CM delivery for digital subtraction angiography
allows a lower total dose of CM = less haemodilation
advantageous for patients with poor CO
why does using intra arterial CM delivery for digital subtraction angiography allow for lwoer total dose
due to difference of distribution of CM when injected into arteries and veins
what does the amount of CM depend on for enteral administration
size of patient and site of examination
what is an advantage of using enteral administration
poor absorption in GI tract so less toxic effects
what is intra thecal CM delivery used for
looking at spinal canal - myelographic exam
what type of contrast media can result in serious adverse reactions if given intra thecally for a myelographic exam
hyperosmolar ionic contrast
why does patient movement need to be limited in intra thecal myelographic exam
to prevent mixing of CM with CSF
intrathecal injections are absorbed from where to where
how does this impact the way its excreted
from CSF to blood stream
excreted in same way as IV CM
why is active manipulation required for direct CM injections in arthrography
to disperse the CM throughout the joint space
how is contrast injection different from IV injection
contrast is not rapidly cleared by kidneys as it is absorbed slowly back by kidneys
what is the difference between hepatobiliary CM and ECF CM
low water solubility than ECf CM and higher plasma protein binding
where does the hepatobiliary CM distribute to in hepatocytes
ECF and intracellularly
what is the 2 ways of excreting hepatobiliary CM and which is the main method
biliary = main
renal
how does the hepatobiliary CM differ from ECF CM in terms of PK variability
what are the 2 reasons for this
PK varies more for hepatobiliary CM
plasma protein binding and hepatobiliary CM is cleared by biliary system so is dependent on liver blood flow
what is the PK of ICM distribution in terms of plasma protein binding level and what kind of ICM they are
are ECF ICM and is very low in PPbinding
what does poor lipid solubility for ICM mean for its distribution
limited distribution to intracellular compartments
why does ICM’s poor lipid solubility cause it to have limited distribution to intracellular compartments
3 things
poor permeability across all membranes
BBB tight endothelial junctions prevent distribution into normal CNS
pathological tissues may be more permeable
what 2 factors influence the intensity and timing of the contrast enhancement
rate and extent of the distribution of CM
ICM is primarily eliminated by what
the kidneys
does ICM undergo metabolism
not really, its negligible
with normal renal function how fast is ICM excreted
all of ICM dose is excreted within 24hrs
what is the elimination half life in normal renal function for ICM
what about renal impairment
1.5-2h
renal impairment = prolonged and can take up to several days
what might be observed in renal impairment for the routes of elimination
increased elimination via hepatic biliary duct
in renal impairment excretion of ICM what might you see in the image that is different from normal renal function excretion
Much lower opacification in kidney as more will be eliminated by biliary and Gi tract so those areas are more
what is the 2 compartment model of ICM excretion
IV injection into vascular compartment/plasma has quick exchange with extravascular compartment
it also has slow excretion into urine
see 2 distinct phases in conc time profile
what is the eGFR
used to identify severely impaired renal function
what are the 3 categories of ICM adverse reactions
acute vs delayed
idiosyncratic vs chemotoxic
renal vs non renal
when do ICM acute adverse reactions occur
<1hr of contrast media administration
what is idiosyncratic adverse reactions
method not well understood but its not dose related so increasing conc will not affect it
what is chemo toxic adverse reaction
related to CM dose and result from CM disrupting homeostasis
what are 3 patient related risk factors for acute reactions
hx of reaction to ICM
asthma
hypersensitivity
what are 2 contrast medium related risk factors for acute reactions
osmolality and iconicity
which types of CM increase risk of acute adverse reactions in terms of osmolality and iconicity
HOCM>LOCM & IOCM
ionic > non ionic CM
when do delayed adverse reactions occur
1h to 1wk after contrast media administration
what are 2 risk factors for delayed adverse reactions
previous late reaction to CM
IL2 treatment
what is contrast induced encephalopathy
acute and reversible neurological deficit
what are 3 symptoms of CIE
transient cortical blindness
transient global amnesia
epilepsy
what kinds of CM have higher incidence of CIE
high osmolality > LOCM
what is the pathogenesis of CIE
BBB suspected involved
high conc of CM can increase BBB permeability causing osmotic pressure changes leading to cerebral edema
how do HOCM affect CIE
hyperosmolality can cause hemodynamic changes which can aggravate cerebral vasospasm
what is contrast induced acute kidney injury
abrupt decline in renal function
what is the serum creatine level change associated with CI-AKI
relative increase of serum creatinine >25% from baseline or rise in serum creatinine within 3 days of exposure to CM
what are the 4 things that ICM can affect that lead to adverse reactions
cytotoxicity and oxidative stress
hyperosmolality
viscosity
RBC deformity
how does ICM induced cytotoxicity and oxidative stress cause injury
2 ways
tubular epithelial cells undergo tubular dysfunction
endothelial cells can undergo dysfunction and vasoconstriction
how does ICM induced hyperosmolality cause injury
intra renal hemodynamic changes
how does ICM induced viscosity cause injury
intra renal hemodynamic changes
what is the final result of all factors of ICM induced acute kidney injury
hypoxia, ischemia, tubular necrosis
what are 5 CI-AKI risk factors related to patients
preexisting renal dysfunction increased age diabetes mellitus dehydration poor renal perfusion
is metformin nephrotoxic
no
are there direct drug drug interactions between metformin and ICM
no
what % of metformin is excreted unchanged in 24hrs and in form are they excreted
90% excreted renally and unchanged form
what 3 factors increasing and decreasing can increase the risk of lactic acidosis
factors that decrease metformin excretion
factors decreasing metabolism of lactate
factors increasing blood lactate levels
what should patients with low eGFR or with AKI do with metformin before procedure
and when should metformin be restarted
stop taking metformin for 48hrs
restarted if renal function has returned to normal
what are 4 CI-AKI CM related risk factors
high osmolality
high viscosity
high injection volume
multiple injections within 3 days
what can ICM do to clotting time
prolong clotting time
does ionic or non ionic agents interact with drugs and can precipitate
ionic agent can precipitate but not an issue with non ionic
what is extravasation
accidental release of injected soln from vein into surrounding tissues
what is air embolism
blood vessel blockage due to air bubbles in the circulatory system
what are 3 patient related risk factors for extravasation
inability to communicate
fragile or damage veins
obesity
what are 3 CM related risk factors for extravasation
high osmolar contrast media
high viscosity contrast media
injecting large volume
what are technique related risk factors for extravasation
power injector
lower limbs and small distal veins
what can IV administration of CM do in pregnancy
ICM can cross the placenta and enter foetal circulation
why is osmolality of CM in pediatrics important
as they are more susceptible to fluid shift
lower tolerance for intravascular osmotic loads
injection of hyperosmolar agents can lead to blood volume expansion and there if there is a large fluid shift then it may lead to cardiac fail and pulmonary edema
why is viscosity of CM in pediatrics important
small gauge angiocatheters in very small blood vessels and there is risk of blood vessel injry
what are 3 things that we need to keep in mind when using CM for the pediatric population
small volumes of CM used
injection site monitored for extravasation
slower injection rate to prolong intravascular acquisition
what are 4 medical considerations for ICM
thyroid disease
myasthenia gravis
phaeochromocytoma
sickle cells disease
why is thyroid disease a medical considerations for ICM
increases risk of developing thyrotoxicosis
why is myasthenia gravis a medical considerations for ICM
breathing difficulty may worsen with ICM
why is phaeochromocytoma a medical considerations for ICM
injection of ICM into adrenal or renal arteries/veins may precipitate a hypertensive crisis
why is sickle cell disease a medical considerations for ICM
high osmolality may induce osmotic shrinkage of RBC and may exacerbate sickle cells
what is the use of barium sulfate
imaging procedures of the GI tract
what is a non iodinated CM
barium sulfate
what is the route of administration for barium sulfate
only oral or rectal routes
what is oral admin of barium sulfate used to visualise
oesophagus and stomach or small intestine
what is rectal admin of barium sulfate used to visualise
rectum and colon
is bariums sulfate absorbed in the normal GI tract
not absorbed
is bariums sulfate distributed widely in the body or is it limited to one area
limited to GI lumen
is bariums sulfate metabolised
no
how is bariums sulfate excreted
excreted unchanged in faeces